Orexigen Therapeutics (OREX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Collaborative agreement: 895K
Today's EPS Names:
PARA, RNTX, SURG, More
Financial Fact:
Collaborative agreement: 895K
Today's EPS Names:
PARA, RNTX, SURG, More
Join SI Premium – FREE
Orexigen Therapeutics (NASDAQ: OREX) reported Q2 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $4.92 million.
For earnings history and earnings-related data on Orexigen Therapeutics (OREX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
